Monies Held in Trust. Subject to Section 2.1(c) and Section 6.4, each Equityholder shall hold all monies received by it that constitute Issuer Pledged Collateral of such Equityholder (including any payment or other benefit in breach of this Section 6.10 or Section 6.11) in trust for the Trustee.
Appears in 2 contracts
Sources: Pledge and Security Agreement (Biocryst Pharmaceuticals Inc), Pledge and Security Agreement (PDL Biopharma, Inc.)
Monies Held in Trust. Subject to Section 2.1(c) and Section 6.4, each the Equityholder shall hold all monies received by it that constitute Issuer Pledged Collateral of such Equityholder (including any payment or other benefit in breach of this Section 6.10 or Section 6.11) in trust for the TrusteeTrustee for the benefit of the Noteholders.
Appears in 2 contracts
Sources: Pledge and Security Agreement (Theravance Biopharma, Inc.), Pledge and Security Agreement (Theravance Biopharma, Inc.)
Monies Held in Trust. Subject to Section 2.1(c) and Section 6.4, each Equityholder shall hold all monies received by it that constitute Issuer Pledged Collateral of such Equityholder (including any payment or other benefit in breach of this Section 6.10 6.11 or Section 6.116.12) in trust for the Trustee, in order to satisfy the Secured Obligations pursuant to the direction of the Trustee.
Appears in 1 contract
Sources: Pledge and Security Agreement (Indevus Pharmaceuticals Inc)